{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T16:33:27Z","timestamp":1758818007605},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1053\/j.ajkd.2013.02.355","type":"journal-article","created":{"date-parts":[[2013,4,6]],"date-time":"2013-04-06T07:46:41Z","timestamp":1365234401000},"page":"52-57","source":"Crossref","is-referenced-by-count":8,"title":["Impact and Interaction of Low Estimated GFR and B Vitamin Therapy on Prognosis Among Ischemic Stroke Patients: The Vitamin Intervention for Stroke Prevention (VISP) Trial"],"prefix":"10.1053","volume":"62","author":[{"given":"Meng","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Markovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Ovbiagele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1053\/j.ajkd.2013.02.355_bib1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/HJR.0b013e32832b8d87","article-title":"Renal function predicts cardiovascular outcomes in Southern Italian postmenopausal women","volume":"16","author":"Perticone","year":"2009","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"issue":"10","key":"10.1053\/j.ajkd.2013.02.355_bib2","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1161\/STROKEAHA.107.513713","article-title":"The association between kidney disease and cardiovascular risk in a multiethnic cohort: findings from the Northern Manhattan Study (NOMAS)","volume":"39","author":"Nickolas","year":"2008","journal-title":"Stroke"},{"issue":"10","key":"10.1053\/j.ajkd.2013.02.355_bib3","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1681\/ASN.2007020256","article-title":"Chronic kidney disease, cardiovascular events, and the effects of perindopril-based blood pressure lowering: data from the PROGRESS Study","volume":"18","author":"Perkovic","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.ajkd.2013.02.355_bib4","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1161\/STROKEAHA.110.612721","article-title":"Factors associated with impaired kidney function and its impact on long-term outcome in young ischemic stroke","volume":"42","author":"Putaala","year":"2011","journal-title":"Stroke"},{"issue":"1","key":"10.1053\/j.ajkd.2013.02.355_bib5","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/ndt\/gfn471","article-title":"Renal dysfunction in acute stroke: an independent predictor of long-term all combined vascular events and overall mortality","volume":"24","author":"Tsagalis","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"16","key":"10.1053\/j.ajkd.2013.02.355_bib6","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1001\/jama.288.16.2015","article-title":"Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis","volume":"288","year":"2002","journal-title":"JAMA"},{"issue":"5","key":"10.1053\/j.ajkd.2013.02.355_bib7","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/jama.291.5.565","article-title":"Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial","volume":"291","author":"Toole","year":"2004","journal-title":"JAMA"},{"issue":"9","key":"10.1053\/j.ajkd.2013.02.355_bib8","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S1474-4422(10)70187-3","article-title":"B Vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial","volume":"9","year":"2010","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.1053\/j.ajkd.2013.02.355_bib9","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S1474-4422(12)70091-1","article-title":"Antiplatelet therapy and the effects of B vitamins in patients with previous stroke or transient ischaemic attack: a post-hoc subanalysis of VITATOPS, a randomised, placebo-controlled trial","volume":"11","author":"Hankey","year":"2012","journal-title":"Lancet Neurol"},{"issue":"11","key":"10.1053\/j.ajkd.2013.02.355_bib10","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/01.STR.0000185929.38534.f3","article-title":"Vitamin Intervention For Stroke Prevention trial: an efficacy analysis","volume":"36","author":"Spence","year":"2005","journal-title":"Stroke"},{"issue":"1","key":"10.1053\/j.ajkd.2013.02.355_bib11","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000054753","article-title":"Vitamin Intervention for Stroke Prevention (VISP) trial: rationale and design","volume":"20","author":"Spence","year":"2001","journal-title":"Neuroepidemiology"},{"issue":"9","key":"10.1053\/j.ajkd.2013.02.355_bib12","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1053\/j.ajkd.2013.02.355_bib13","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ahj.2011.06.006","article-title":"Prognostic assessment of estimated glomerular filtration rate by the new Chronic Kidney Disease Epidemiology Collaboration equation in comparison with the Modification of Diet in Renal Disease Study equation","volume":"162","author":"Skali","year":"2011","journal-title":"Am Heart J"},{"key":"10.1053\/j.ajkd.2013.02.355_bib14","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"10.1053\/j.ajkd.2013.02.355_bib15","series-title":"Advances in Survival Analysis: Handbook of Statistics","first-page":"1","article-title":"Evaluation of the performance of survival analysis models: discrimination and calibration measures","author":"D'Agostino","year":"2004"},{"issue":"1-2","key":"10.1053\/j.ajkd.2013.02.355_bib16","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jns.2009.09.020","article-title":"Relation of baseline presence and severity of renal disease to long-term mortality in persons with known stroke","volume":"288","author":"Ani","year":"2010","journal-title":"J Neurol Sci"},{"key":"10.1053\/j.ajkd.2013.02.355_bib17","doi-asserted-by":"crossref","first-page":"c4249","DOI":"10.1136\/bmj.c4249","article-title":"Low glomerular filtration rate and risk of stroke: meta-analysis","volume":"341","author":"Lee","year":"2010","journal-title":"BMJ"},{"issue":"2","key":"10.1053\/j.ajkd.2013.02.355_bib18","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1586\/ern.10.204","article-title":"Reno-cerebrovascular disease: linking the nephron and neuron","volume":"11","author":"Lee","year":"2011","journal-title":"Expert Rev Neurother"},{"issue":"8","key":"10.1053\/j.ajkd.2013.02.355_bib19","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1097\/01.ASN.0000132474.50966.DA","article-title":"Endothelial dysfunction","volume":"15","author":"Endemann","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2013.02.355_bib20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/CIRCULATIONAHA.106.678342","article-title":"Chronic kidney disease: effects on the cardiovascular system","volume":"116","author":"Schiffrin","year":"2007","journal-title":"Circulation"},{"issue":"5","key":"10.1053\/j.ajkd.2013.02.355_bib21","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1046\/j.1523-1755.2002.00600.x","article-title":"The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia","volume":"62","author":"Himmelfarb","year":"2002","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ajkd.2013.02.355_bib22","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1523-1755.2003.00702.x","article-title":"Oxidative stress and dysregulation of superoxide dismutase and NADPH oxidase in renal insufficiency","volume":"63","author":"Vaziri","year":"2003","journal-title":"Kidney Int"},{"issue":"10","key":"10.1053\/j.ajkd.2013.02.355_bib23","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.jacc.2011.05.028","article-title":"Homocysteine and reclassification of cardiovascular disease risk","volume":"58","author":"Veeranna","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1053\/j.ajkd.2013.02.355_bib24","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S1474-4422(07)70219-3","article-title":"Homocysteine-lowering therapy: a role in stroke prevention?","volume":"6","author":"Spence","year":"2007","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.1053\/j.ajkd.2013.02.355_bib25","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1001\/jama.2010.1106","article-title":"B-Vitamin therapy for diabetic nephropathy: reply","volume":"304","author":"Spence","year":"2010","journal-title":"JAMA"},{"issue":"8","key":"10.1053\/j.ajkd.2013.02.355_bib26","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1093\/ndt\/12.8.1622","article-title":"Abnormal cyanide metabolism in uraemic patients","volume":"12","author":"Koyama","year":"1997","journal-title":"Nephrol Dial Transplant"},{"issue":"16","key":"10.1053\/j.ajkd.2013.02.355_bib27","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1001\/jama.2010.490","article-title":"Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial","volume":"303","author":"House","year":"2010","journal-title":"JAMA"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638613005519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638613005519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,17]],"date-time":"2018-10-17T04:22:50Z","timestamp":1539750170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638613005519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0272638613005519"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2013.02.355","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}